Coforge Builds Robust Healthcare Muscle: Charting AI-Powered Growth in March 2026

Coforge Limited is aggressively fortifying its presence in the burgeoning healthcare sector, demonstrating a decisive strategic pivot that is already yielding significant results. The company's 'other businesses' segment, which encompasses healthcare alongside hi-tech and retail, witnessed an impressive 70.7% year-on-year growth in FY25, contributing a substantial 26% to its overall revenues. This robust performance underscores Coforge’s successful diversification beyond its traditional strongholds in Banking, Financial Services and Insurance (BFSI) and Travel, Transportation & Hospitality (TTH), positioning it as a formidable player in India's rapidly expanding healthcare IT landscape.

The Catalyst

Coforge's sharpened focus on healthcare as a distinct growth vertical over the past two years has been a calculated move to capitalize on the increasing digitization and AI adoption within the global healthcare industry. The strategic acquisition of Cigniti, an AI and IP-led digital assurance and engineering services company, has been a pivotal accelerator in this vertical expansion. Furthermore, significant partnerships with prominent entities like Innovaccer and VHC Health, coupled with notable public sector engagements, have cemented Coforge's commitment to scaling its healthcare offerings. The Indian IT sector's overall outlook for healthcare IT services is exceptionally positive, with spending projected to reach $13.5 billion by 2026. The global AI in healthcare market is also on a rapid growth trajectory, expected to reach $6.92 billion by 2030, indicating a fertile ground for Coforge's AI-infused healthcare solutions.

Financial Forensics

FY25 proved to be a landmark year for Coforge, with consolidated revenue soaring to ₹12,050.7 crore (US$1.45 billion), marking a 33.8% year-on-year growth in INR terms and 32.0% in constant currency. While BFSI and TTH remain core contributors, the standout performance of the 'other businesses' segment, primarily driven by healthcare, highlights a meaningful shift in revenue composition. This segment's exceptional 70.7% growth in FY25 significantly outpaced the company's overall robust growth, reflecting the strategic importance and high potential of its diversified ventures.

Here’s a snapshot of Coforge's financial performance illustrating this strategic shift:

Metric	FY25 (₹ Crore)	FY25 (YoY Growth in %)	Contribution to Total Revenue (%)
Total Consolidated Revenue	12,050.7	33.8%	100%
'Other Businesses' Segment	3,133.2	70.7%	26%

Note: The 'Other Businesses' segment revenue is an estimation based on 26% of the total consolidated revenue.

This data clearly indicates that Coforge's deliberate expansion into healthcare is not just a peripheral activity but a material driver of its overall financial expansion.

Market Impact

Coforge's aggressive foray into healthcare, particularly with its focus on AI-led digital assurance and engineering services through the Cigniti acquisition, positions it strategically in a highly competitive market. The acquisition significantly enhances Coforge's capabilities in critical areas such as platform modernization, cloud-native transformation, hyper-automation, and AI-led product engineering. Cigniti's proprietary platforms, including BlueSwan, Zastra, and iNSta, infused with Generative AI, are instrumental in accelerating digital transformation, especially in regulated industries like healthcare where compliance and data integrity are paramount.

The partnership with Innovaccer, a leading healthcare AI company, is another significant development. Launched on January 26, 2026, the G-Forge initiative combines Innovaccer's Gravity platform with Coforge's global implementation network, aiming to accelerate AI adoption across providers, payers, life sciences firms, and health-tech startups. This collaboration will focus on developing industry-specific accelerators in areas like revenue cycle management, care management, and member/provider experience, with Coforge establishing a Healthcare AI Center of Excellence.

Furthermore, Coforge's expansion into the US provider market through its strategic partnership with VHC Health, announced on February 26, 2026, marks a crucial milestone. This engagement sees Coforge as VHC Health’s digital and IT services provider, leading end-to-end transformation across infrastructure, cloud, digital workplace, and cybersecurity, including migration to AWS and implementation of ServiceNow. This strengthens Coforge's Provider Experience Management capabilities and underscores its ability to deliver AI-infused transformation at an enterprise scale for healthcare systems.

Analysts have a positive outlook on Coforge's share price for 2026, with targets ranging from ₹1,250 to ₹1,450, reflecting confidence in its business expansion and long-term strategy. The company’s strong order intake of $2.1 billion in Q4 FY25, including a $1.56 billion TCV deal, further reinforces revenue visibility for FY26 and beyond.

Key Takeaways

• Accelerated Healthcare Growth: Coforge’s 'other businesses' segment, driven significantly by healthcare, grew 70.7% YoY in FY25, becoming a major revenue contributor.

• Strategic Acquisitions: The integration of Cigniti has bolstered Coforge's capabilities in AI-led digital assurance, quality engineering, and platform modernization, crucial for regulated industries like healthcare.

• AI-Powered Partnerships: Collaborations with Innovaccer (G-Forge initiative) and investments in verticalized AI capabilities demonstrate a strong commitment to AI transformation in healthcare.

• Global Market Penetration: New deals with public healthcare providers in the UK and the strategic partnership with VHC Health in the US signify successful expansion into critical international markets.

• Comprehensive Digital Transformation: Coforge is offering end-to-end services, including cloud migration, cybersecurity, and AI-driven operations, vital for modern healthcare systems.

• Positive Analyst Sentiment: Financial analysts generally maintain a "Buy" rating for Coforge, with optimistic share price targets for 2026, reflecting the company's growth trajectory and strategic initiatives.

FinScann Verdict

FinScann analysis indicates that Coforge's deliberate and well-executed strategy to build its healthcare muscle is a significant long-term growth driver. The combination of strategic acquisitions, deep-seated partnerships, and a strong focus on AI-led digital transformation positions Coforge to capture a substantial share of the expanding global healthcare IT market. Investors should monitor the continued integration of Cigniti and the execution of key AI initiatives for sustained value creation.

Q: How has Coforge's Cigniti acquisition strengthened its healthcare capabilities?

A: The acquisition of Cigniti, an AI and IP-led digital assurance and engineering services company, has materially strengthened Coforge's quality engineering, testing, and platform modernization capabilities. These areas are especially critical for the regulated healthcare industry, ensuring compliance, data integrity, and operational resilience.

Q: What is the significance of the Innovaccer partnership for Coforge's healthcare growth?

A: The partnership with Innovaccer, launched as the G-Forge initiative, aims to accelerate AI transformation in healthcare. Coforge will leverage Innovaccer's Gravity platform and its own implementation expertise to help healthcare organizations scale AI, integrate siloed data, and improve decision-making, offering industry-specific accelerators for critical areas like revenue cycle and care management.

Q: How is Coforge expanding its presence in the US healthcare market?

A: Coforge is making significant inroads into the US healthcare provider market through a strategic partnership with VHC Health. Under this agreement, Coforge will serve as VHC Health's digital and IT services provider, leading comprehensive digital transformation efforts including infrastructure modernization, cloud migration to AWS, cybersecurity enhancements, and the deployment of AI-driven operational solutions.

Q: What is the outlook for AI in the Indian healthcare sector?

A: The Indian AI in healthcare market is poised for substantial expansion, with reports estimating a remarkable CAGR of 40.6% to reach $1.6 billion by 2025. This growth is driven by increasing demand for AI technologies in medical imaging, diagnostics, personalized treatments, and administrative workflow efficiencies, backed by government initiatives like the Digital India program and rising healthcare expenditure.

Disclaimer: For information only; not investment advice. Stock market investments carry risks. Please consult a SEBI-registered advisor before investing. FinScann assumes no liability for decisions made based on this report.